---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-036711"
form_type: "8-K"
ticker: "BCDA"
cik: "0000925741"
company_name: "BioCardia, Inc."
filed_at: "2025-12-03T23:59:59+00:00"
generated_at: "2026-05-16T15:34:58.066624+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# BioCardia elects Marvin Slosman to board; Dr. Richard Krasno completes term

## Summary
- Marvin Slosman, CEO of InspireMD, elected to BioCardia board effective Dec. 2, 2025.
- Dr. Richard Krasno, a director since 2016, completed his term and departed the board on Dec. 2, 2025.
- At the annual meeting, shareholders elected Slosman, Jay M. Moyes, and Simon H. Stertzer as Class III directors.
- Shareholders also approved amendment to 2016 Equity Incentive Plan extending term to 2035 and increasing share reserve.
- Ratification of PKF San Diego as auditor approved; advisory vote on executive compensation passed.

## SEC filing metadata
- accession: 0001437749-25-036711
- form_type: 8-K
- ticker: BCDA
- cik: 0000925741
- company_name: BioCardia, Inc.
- filed_at: 2025-12-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 5.07, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/925741/000143774925036711/0001437749-25-036711-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/925741/000143774925036711/bcda20251202_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-036711
- JSON: https://secwatch.observer/filing/0001437749-25-036711.json
- Plain text: https://secwatch.observer/filing/0001437749-25-036711.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.